Invesaro

Stocks Health care PIII

NASDAQ · Health care

P3 Health Partners Inc. (PIII)

P3 Health Partners Inc. brought in $1.5B of revenue over the twelve months to June 30, 2026, up 2.8% from a year earlier. It posted a net loss of $98.4M. At June 30, 2026 it held $21.3M in cash against $119.9M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.

Free, no password. An email when PIII files with the SEC.

Price
$4.25
+6.25% on the day · November 9, 2026
52-week range $1.52 to $16.89
Market cap
$30.9M
Revenue (last 12 months)
$1.5B
+2.8% year on year
Net margin
-6.6%

Key facts about P3 Health Partners Inc.

Net worth
P3 Health Partners Inc. has a market value (market cap) of $30.9M at the latest share price, and shareholders' equity of $73.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2024 revenue was $1.5B (-2.8% year on year), with a net loss of $147.9M. Over the 12 months to June 30, 2026: revenue $1.5B, net loss $98.4M.
Cash flow
In fiscal 2024 operations used $91.2M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 10, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
P3 Health Partners Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What P3 Health Partners Inc. does

P3 Health Partners Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker PIII.

Revenue and profit by year

Revenue
FY19: $145.5M $145.5M FY19FY21: $491.1M $491.1M FY21FY22: $1B $1B FY22FY23: $1.3B $1.3B FY23FY24: $1.5B $1.5B FY24FY24: $1.5B $1.5B FY24
Net income
FY19: -$42M -$42M FY19FY21: -$31.4M -$31.4M FY21FY22: -$270.1M -$270.1M FY22FY23: -$57.8M -$57.8M FY23FY24: -$135.8M -$135.8M FY24FY24: -$147.9M -$147.9M FY24

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2024$1.5B-$270.3M-$147.9M-$45.26n/a
2024$1.5B-$320.7M-$135.8M-$54.06-$110.1M
2023$1.3B-$167.9M-$57.8M-$31.54-$77.9M
2022$1B-$1.6B-$270.1M-$325.36-$128.3M
2021$491.1M-$28.6M-$31.4Mn/a-$27.5M
2019$145.5M-$39.5M-$42Mn/a-$29.7M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 14, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where PIII ranks in Health care

Revenue$1.5B
#131 of 751 in Health care · Top 17%
Revenue growth-2.8%
#437 of 532 in Health care · Bottom 18%
Net margin-10.1%
#286 of 544 in Health care · Bottom 48%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What P3 Health Partners Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 11, 2026
  2. August 12, 2026
  3. August 10, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 8.6% to $386.4M versus the same quarter last year; diluted EPS -$0.63 versus -$6.23.
  4. August 10, 2026
  5. July 6, 2026
  6. June 10, 2026
  7. May 26, 2026
  8. May 15, 2026
  9. May 14, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 3.5% to $386.4M versus the same quarter last year; diluted EPS $0.32 versus -$6.28.
  10. May 14, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 14, 2026. Insider transactions on SEC

Insider trades

What the people running P3 Health Partners Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 13, 2026 Hudson Vegas Investment SPV, LLC10% owner Exercised options 100,000 - - Form 4
August 13, 2026 Hudson Vegas Investment SPV, LLC10% owner Other change 100,000 - - Form 4
August 10, 2026 Hudson Vegas Investment SPV, LLC10% owner Sold 1,041 $13.38 $13.9K Form 4
August 10, 2026 Hudson Vegas Investment SPV, LLC10% owner Sold 19,074 $16.05 $306.1K Form 4
August 10, 2026 Hudson Vegas Investment SPV, LLC10% owner Sold 29,885 $16.86 $503.9K Form 4
June 10, 2026 Hudson Vegas Investment SPV, LLC10% owner Exercised options 50,000 - - Form 4
June 10, 2026 Hudson Vegas Investment SPV, LLC10% owner Other change 50,000 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PIII

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Chicago Pacific Founders UGP III, LLC13D, may seek influence with 11 related filers 49.99% 6,210,082 June 6, 2025
Leavitt Equity Partners III, L.P.13D, may seek influence with 6 related filers 19.6% 31,601,912 June 26, 2024
Hudson Vegas Investment SPV, LLC13D, may seek influence with 2 related filers 17.5% 829,651 August 12, 2026
Alyeska Investment Group, L.P.13G, passive with 2 related filers 9.99% 16,014,443 November 14, 2024

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1 managers reported a position.

HolderSharesValueChange on quarter
Trinity Financial Advisors LLC33,540$362.2K+6,483

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

8 insiders reported holding 880,299 shares in total, about $3.7M at the last price.

HolderSharesAs of
Hudson Vegas Investment SPV, LLC10% owner 829,651 August 13, 2026
Thierer MarkDirector 12,662 August 6, 2025
Park Jeffrey GDirector 6,331 August 6, 2025
Wasson Gregory DDirector 6,331 August 6, 2025
Leisure Lawrence B.Director 6,331 August 6, 2025
Price Thomas EdmundsDirector 6,331 August 6, 2025
Kazarian Gregory N.Director 6,331 August 6, 2025
Tolan Mary ADirector 6,331 August 6, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PIII

What does P3 Health Partners Inc. do?

P3 Health Partners Inc. is a company in the Health care sector, listed on NASDAQ as PIII. Its shares trade on NASDAQ under the ticker PIII.

What is P3 Health Partners Inc.'s net worth?

P3 Health Partners Inc. has a market value (market cap) of $30.9M at the latest share price, and shareholders' equity of $73.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is P3 Health Partners Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $98.4M on revenue of $1.5B.

How much revenue does P3 Health Partners Inc. make?

Over the twelve months to June 30, 2026 P3 Health Partners Inc. reported revenue of $1.5B. That is 2.8% more than a year earlier.

When did P3 Health Partners Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 11, 2026.

When is P3 Health Partners Inc.'s next earnings report?

P3 Health Partners Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare PIII with

Compare PIII with any company

Follow PIII

Get an email when P3 Health Partners Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when PIII files with the SEC.

Where the numbers come from

Financial figures are the values P3 Health Partners Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.